Discussion
in
Workshop: New Frontiers of AI for Drug Discovery and Development
Roundtable Discussion
Abstract:
Karen Sayal (GSK): The Opportunities and Challenges of Integrating ML into Clinical Trials
Bülent Kiziltan (Novartis): From Drug Discovery to Drug Design: AI-driven Generative Chemistry
Haoda Fu (Eli Lilly): AI/ML Based De Novo Design for Biologics
Quanquan Gu (UCLA/ByteDance): TBA
Chat is not available.